BCL10 and B-cell non-Hodgkin lymphoma: Previous studies found that LUBAC is critical for optimal NF-κB activation downstream of immune receptor signalling in B-cell lymphomas and Jurkat T cells by associating with the CARD11/BCL-10/MALT1 (CBM) complex34, 35.